Institutional investors purchased a net $3.2 million shares of OHRP during the quarter ended March 2014. This may signal that the smart money is gaining interest in this company as the 27.54% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
VISIUM ASSET MANAGEMENT LP Bought 1.2 Million shares of OHR Pharmaceutical Inc